PROF(Profound Medical Corp.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $6.87M | $6.68M | $7.20M | $10.68M | $16.10M |
| 毛利润 | $2.95M | $3.02M | $4.31M | $7.04M | $11.39M |
| 营业利润 | −$30.29M | −$32.13M | −$28.65M | −$33.06M | −$41.25M |
| 净利润 | −$30.70M | −$28.67M | −$28.32M | −$27.82M | −$42.57M |
| 经营现金流 | −$22.36M | −$25.80M | −$22.61M | −$23.45M | −$38.21M |
| 自由现金流 | −$22.39M | — | — | — | −$38.38M |
| 摊薄每股收益 | — | — | — | $1.12 | $1.41 |